Akiram Therapeutics and ITM signed a Lu-177 supply agreement to support AKIR001 development in Solid...

Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate

VERAXA Biotech and Ardigen collaborate to accelerate AI-enabled BiTAC pipeline development

Protina partners with Onconic Therapeutics on next-generation cancer drugs

RyboDyn partners with U.S. Department of War to advance AI-discovered ADC therapies for Lung cancer

Lonza and InduPro announce licensing agreement to advance next-generation ADC therapeutics

Lonza grants Antharis exclusive license to develop dual-payload ADCs for GI cancers

AmMax Bio licenses antibody-drug conjugate technology for Hematological cancers from Lonza

Johnson & Johnson to acquire Firefly Bio to expand oncology pipeline with degrader ADC platform